Search Results - Emma Moore

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Krebspatienten können nicht warten by Murray Aitken, Emma Moore

    Published in Monitor Versorgungsforschung (2021-08-01)
    Get full text
    Article


  2. 2

    Is a smartphone application (BlueIce) acceptable and safe for university students who self-harm: an open study by Emma Moore, Paul Stallard, Bethany Cliffe, Kathryn Whittle

    Published in BMJ Open (2024-04-01)
    Get full text
    Article


  3. 3

    Creation and Distribution of 2021–2023 New York City Regional Antibiograms by William Greendyke, Elise Mantell, Emma Moore, Elizabeth Cave, Molly Kratz

    Get full text
    Article


  4. 4

    Acceptability, use and safety of the BlueIce self-harm prevention app: qualitative findings from the Beating Adolescent Self-Harm (BASH) randomised controlled trial by Gordon Taylor, Emma Moore, Antonieta Medina-Lara, Shelley Rhodes, Paul Stallard, Nia Morrish, Bethany Cliffe, Kathryn Whittle

    Published in BMJ Mental Health (2024-05-01)
    Get full text
    Article


  5. 5

    Long-Term Safety of PEGylated Coagulation Factor VIII in the Immune-Deficient Rowett Nude Rat by Caroline E. Rasmussen, Jette Nowak, Julie M. Larsen, Emma Moore, David Bell, Kai Chiu Liu, Nanna Skall Sorensen, Wendela A. Kappers, Thomas Krogh-Meibom, Hanne Offenberg

    Published in Journal of Toxicology (2017-01-01)
    Get full text
    Article


  6. 6

    Author Correction: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials by Gennaro Pagano, Dylan Trundell, Tanya Simuni, Nicola Pavese, Kenneth Marek, Ronald B. Postuma, Nima Shariati, Annabelle Monnet, Emma Moore, Evan W. Davies, Hanno Svoboda, Nathalie Pross, Azad Bonni, Tania Nikolcheva, for the PASADENA Investigators, Prasinezumab Study Group

    Published in npj Parkinson's Disease (2025-08-01)
    Get full text
    Article


  7. 7

    Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials by Gennaro Pagano, Dylan Trundell, Tanya Simuni, Nicola Pavese, Kenneth Marek, Ronald B. Postuma, Nima Shariati, Annabelle Monnet, Emma Moore, Evan W. Davies, Hanno Svoboda, Nathalie Pross, Azad Bonni, Tania Nikolcheva, for the PASADENA Investigators, Prasinezumab Study Group

    Published in npj Parkinson's Disease (2025-07-01)
    Get full text
    Article


Search Tools: